Heming Zhou

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry

G. Fan, Ji-gang Zhang, Qin Li, 2019, Journal of Cancer.

Rho kinase mediates transforming growth factor-β1-induced vasculogenic mimicry formation: involvement of the epithelial-mesenchymal transition and cancer stemness activity.

Gao-lin Liu, Ji-gang Zhang, Qin Li, 2020, Acta biochimica et biophysica Sinica.

The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.

Gao-lin Liu, Ji-gang Zhang, Qin Li, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

Ji-gang Zhang, Qin Li, Xue Zhang, 2021, Signal Transduction and Targeted Therapy.

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy

Yafei Wu, Gao-lin Liu, Ji-gang Zhang, 2020, Frontiers in Pharmacology.

Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling

Gao-lin Liu, Ji-gang Zhang, Qin Li, 2020, BMC Cancer.

Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells

R. Blaheta, W. Bechstein, J. Rutz, 2022, Cancers.

Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.

Ji-gang Zhang, Xue Zhang, Heming Zhou, 2024, Experimental cell research.

A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC

Gao-lin Liu, Qin Li, Heming Zhou, 2023, Cancer & metabolism.